The emerging pathological mechanism of coronary microvascular dysfunction: a narrative review
Xingjiang Xiong , Jie Wang , Li Ren , Zhaoling Li , Yangyang Liu , Pu Xia , Lian Duan
Metabolism and Target Organ Damage ›› 2025, Vol. 5 ›› Issue (4) : 54
The emerging pathological mechanism of coronary microvascular dysfunction: a narrative review
Thirty to forty percent of patients undergoing angiography for chest pain and tightness show no abnormalities in the large coronary arteries. This phenomenon is particularly common among women, with more than 50% affected. Research has identified coronary microvascular dysfunction (CMD) as a key underlying cause; however, its pathological mechanisms remain poorly understood. In this article, we explore the relationship between CMD and coronary artery disease and summarize the current knowledge on the pathological origins of CMD, which include endothelial dysfunction, inflammation, oxidative stress, left ventricular hypertrophy and mitochondrial abnormalities. Special emphasis is placed on pathological mechanisms contributing to the higher incidence of CMD in women.
Coronary microvascular dysfunction / pathological mechanism / endothelial remodeling / women / coronary artery disease
| [1] |
Pepine CJ, Ferdinand KC, Shaw LJ, et al; ACC CVD in Women Committee. Emergence of nonobstructive coronary artery disease: a woman’s problem and need for change in definition on angiography. J Am Coll Cardiol. 2015;66:1918-33. PMCID:PMC4618799 |
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
Kelshiker MA, Seligman H, Howard JP, et al; Coronary Flow Outcomes Reviewing Committee. Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis. Eur Heart J. 2022;43:1582-93. PMCID:PMC9020988 |
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
|
| [61] |
|
| [62] |
|
| [63] |
|
| [64] |
|
| [65] |
|
| [66] |
|
| [67] |
|
| [68] |
|
| [69] |
|
| [70] |
|
| [71] |
|
| [72] |
|
| [73] |
|
| [74] |
|
| [75] |
|
| [76] |
|
| [77] |
|
| [78] |
|
| [79] |
|
| [80] |
|
| [81] |
|
| [82] |
|
| [83] |
|
| [84] |
|
| [85] |
|
| [86] |
|
| [87] |
|
| [88] |
|
| [89] |
|
| [90] |
|
| [91] |
|
| [92] |
|
| [93] |
|
| [94] |
|
| [95] |
|
| [96] |
|
| [97] |
|
| [98] |
|
| [99] |
|
| [100] |
|
| [101] |
|
| [102] |
|
| [103] |
|
| [104] |
|
| [105] |
|
| [106] |
|
| [107] |
|
| [108] |
|
| [109] |
|
| [110] |
|
| [111] |
|
| [112] |
|
| [113] |
|
| [114] |
|
| [115] |
|
| [116] |
|
| [117] |
|
| [118] |
|
| [119] |
|
| [120] |
|
| [121] |
|
| [122] |
|
| [123] |
|
| [124] |
|
| [125] |
|
| [126] |
|
| [127] |
|
| [128] |
|
| [129] |
|
| [130] |
|
| [131] |
|
| [132] |
|
| [133] |
|
| [134] |
|
| [135] |
|
| [136] |
|
| [137] |
|
| [138] |
|
| [139] |
|
| [140] |
|
| [141] |
Pedro JM, Kroemer G, Galluzzi L. Autophagy and mitophagy in cardiovascular disease.Circ Res2017;120:1812-24 |
| [142] |
|
| [143] |
|
/
| 〈 |
|
〉 |